Global Cord Blood Corporation Share Price Deutsche Boerse AG
Equities
6CB
KYG393421030
Healthcare Facilities & Services
Sales 2021 | 1.16B 160M 149M 12.54B | Sales 2022 | 1.24B 171M 160M 13.44B | Capitalization | 2.97B 409M 381M 32.09B |
---|---|---|---|---|---|
Net income 2021 | 508M 70.03M 65.21M 5.49B | Net income 2022 | 501M 69.07M 64.31M 5.42B | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 837M 780M 65.67B | Net cash position 2022 | 6.66B 918M 855M 72.02B | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 31/12/08 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 31/12/08 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 31/10/04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 31/12/08 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 31/12/08 |
Director/Board Member | 56 | 31/12/08 |
1st Jan change | Capi. | |
---|---|---|
+25.40% | 89.38B | |
-24.34% | 75.67B | |
+6.34% | 28.83B | |
+5.20% | 18.25B | |
-14.04% | 16.51B | |
+2.57% | 15.72B | |
+77.58% | 13.71B | |
+80.23% | 13.46B | |
+23.33% | 12.64B |